Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
11/2007
11/01/2007US20070254835 Composition and method for treating neurological disorders
11/01/2007US20070254833 Compositions and methods for treating diverticular disease
11/01/2007US20070254827 Alpha-aminobenzyl-alpha,alpha,-diphosphoric acid selective chelation of beryllium
11/01/2007US20070254370 Method and kit for detecting the early onset of renal tubular cell injury
11/01/2007US20070254363 Substituted biaryl compounds for inflammation and immune-related uses
11/01/2007US20070254354 Production of Isoprenoids
11/01/2007US20070254329 Mammalian Genes Involved in Viral Infection and Tumor Suppression
11/01/2007US20070254318 Inhibition of cell proliferation
11/01/2007US20070254287 Diagnostics and Therapeutics for Diseases Associated with Dipeptidyl-Peptidase 10 (Dpp10)
11/01/2007US20070254055 Therapeutic Avenanthramide Compounds
11/01/2007US20070254050 Method for treatment of diarrhea-predominant irritable bowel syndrome
11/01/2007US20070254046 such as 4-Aminomethyl-N-[4-(5-biphenyl-4-yl-pyrazolo[1,5-c]pyrimidin-7-ylamino)-phenyl]-benzamide, useful in the therapy of (hyper)proliferative diseases and/or disorders responsive to induction of apoptosis
11/01/2007US20070254045 Method for treating head and neck cancer
11/01/2007US20070254043 Sprayable beautifying composition
11/01/2007US20070254040 Nutritional supplement and use thereof
11/01/2007US20070254038 Microspheroidal Controlled Release Of Biomolecules
11/01/2007US20070254037 Methods and Compositions for the Treatment of Cell Proliferation
11/01/2007US20070254036 Treatment of menopause associated symptoms
11/01/2007US20070254032 Osmotic drug delivery system
11/01/2007US20070254031 Rapidly disintegrable solid preparation
11/01/2007US20070254030 Tablets; contains diuretic such as hydrochlorothiazide
11/01/2007US20070254029 Method for ameliorating muscle weakness/wasting in a patient infected with human immunodeficiency virus-type 1
11/01/2007US20070254028 Granules Comprising a Nsaid and a Sugar Alcohol Made by Melt Extrusion
11/01/2007US20070254027 Compositions and methods useful for treatment of respiratory illness
11/01/2007US20070254026 Softgel capsules
11/01/2007US20070254025 Oral contraceptive and acne medication combination and treatment of acne with reduced side effects
11/01/2007US20070254023 Perorally Administrable Antimicrobial Composition
11/01/2007US20070254022 Cationic liposome delivery of taxanes to angiogenic blood vessels
11/01/2007US20070254019 Method for treating brain cancer
11/01/2007US20070254014 Flexible, compressed intravaginal rings, methods of making and using the same, and apparatus for making the same
11/01/2007US20070254009 Antibiotic/bone morphogenic protein formulation and method of treatment
11/01/2007US20070254008 Antibiotic formulation and method of treatment
11/01/2007US20070254003 Non-sticky coatings with therapeutic agents for medical devices
11/01/2007US20070253998 Drug delivery to iliohypogastric nerve to alleviate chronic pelvic pain
11/01/2007US20070253997 Drug delivery to alleviate chronic pelvic pain
11/01/2007US20070253995 Drug Delivery Methods and Devices for Treating Stress Urinary Incontinence
11/01/2007US20070253994 Intraspinal Drug Delivery Methods and Devices To Alleviate Chronic Pelvic Pain
11/01/2007US20070253988 Methods for peeling skin
11/01/2007US20070253983 Augmentation of titer for vaccination in animals
11/01/2007US20070253977 Recombinant respiratory syncytial virus (RSV) strains deleted of the region of G protein most likely to induce unwanted type 2 T cell responses in susceptible recipients; engineered using reverse genetics with deletions of amino acids 151-221 and 178-219; for immunogenic compositions against RSV
11/01/2007US20070253971 Circovirus sequences associated with piglet weight loss disease (PWD)
11/01/2007US20070253957 Substituted N-Aryl-1H-Pyrazolo[3,4-B]Quinolin-4-Amines and Analogs as Activators of Caspases and Inducers of Apoptosis
11/01/2007US20070253956 Method for opening tight junctions
11/01/2007US20070253955 Methods for altering fertility
11/01/2007US20070253954 Epha4 As Therapeutic Target Of Prc And Pdaca
11/01/2007US20070253952 Multifunctional and Multivalent Angiogenesis Inhibitors
11/01/2007US20070253946 Axon Regeneration Promoter
11/01/2007US20070253944 Use of creatine or creatine compounds for skin preservation
11/01/2007US20070253943 Compositions for Topical Treatment
11/01/2007US20070253941 Coenzyme Q10, lactoferrin and angiogenin compositions and uses thereof
11/01/2007US20070253934 New strain of lactic acid bacterium and edible compositions, drugs and veterinary products containing it
11/01/2007US20070253928 Pharmaceutical removal of neuronal extensions from a degenerating disc
11/01/2007US20070253925 Silicon-based tocopherol derivatives
11/01/2007US20070253924 Administration of 4-aminopiperidine compounds for inducing and/or stimulating the growth of keratin fibers and/or preventing loss thereof
11/01/2007US20070253909 Aqueous Antiseptic Solution and Compatible Cationic Dye for Staining Skin
11/01/2007US20070253906 Identifying Amyloid precurser protein lowering agents; non-steroidal anti-inflammatory drug (NSAID); Alzheimer's disease
11/01/2007US20070253905 Abeta42 LOWERING AGENTS
11/01/2007US20070253900 The 98P4B6 gene, its fragment, its encoded protein, variants , or a fragment, can be used to elicit a humoral or cellular immune response; antibodies or T cells reactive with 98P4B6 can be used in active or passive immunization
11/01/2007US20070253896 7,9-Dihydro-Purin-8-One and Related Analogs as HSP90-Inhibitors
11/01/2007US20070252295 Amphoteric liposomes containing positive and negative membrane-based or membrane forming charge carriers and having an isoelectric point of between 4 and 8; pH-sensitive liposomes comprise, in particular, cholesterol hemisuccinate
11/01/2007CA2650922A1 Pre-mixed, ready-to-use nicardipine compositions
11/01/2007CA2650311A1 Improved treatment of cystic fibrosis
11/01/2007CA2650211A1 Asymmetric membranes for drug delivery devices
11/01/2007CA2650196A1 Pyrimidine derivatives as pi3k inhibitors
11/01/2007CA2650171A1 Ophthalmic and related aqueous solutions containing antifungal agents, uses therefor and methods for preparing them
11/01/2007CA2650124A1 Oxadiazolidinedione compound
11/01/2007CA2650057A1 Phenyl- or pyridinyl-amide as inhibitors of c-fms kinase
11/01/2007CA2650033A1 Compositions and methods useful for treatment of respiratory illness
11/01/2007CA2650027A1 Induction of weight loss and the selective inhibition of ptp1b
11/01/2007CA2650009A1 Il-8 receptor antagonists
11/01/2007CA2650007A1 Il-8 receptor antagonists
11/01/2007CA2650006A1 Substituted biphenyl carboxylic acids and derivatives thereof
11/01/2007CA2649924A1 Inhibitors of c-fms kinase
11/01/2007CA2649919A1 Phenyl-and pyridinyl amide inhibitors of c-fms kinase
11/01/2007CA2649915A1 Polymeric compositions and methods of making and using thereof
11/01/2007CA2649881A1 Treatment of inflammatory and ulcerative diseases of the bowel with opioid antagonists
11/01/2007CA2649845A1 Terphenyl derivatives for treatment of alzheimer' s disease
11/01/2007CA2649762A1 Synthesis and uses of pyroglutamic acid derivatives
11/01/2007CA2649755A1 Method of inhibiting c-kit kinase
11/01/2007CA2649739A1 Inhibitors of c-fms kinase
11/01/2007CA2649736A1 Heterocyclic compounds as inhibitors of c-fms kinase
11/01/2007CA2649713A1 Antispermatogenic, spermicidal and/or antifungal composition and methods of using the same
11/01/2007CA2649636A1 Diazepan derivatives modulators of chemokine receptors
11/01/2007CA2649631A1 Vaccine against nicotine addiction
11/01/2007CA2649628A1 Pharmaceutical product
11/01/2007CA2649620A1 Novel low dose pharmaceutical compositions comprising nimesulide, preparation and use thereof
11/01/2007CA2649589A1 Novel polypeptides and use thereof
11/01/2007CA2649575A1 Treatment of melanoma
11/01/2007CA2649556A1 Pharmaceutical solution formulations for pressurised metered dose inhalers
11/01/2007CA2649543A1 Thieno-[2,3-d]pyrimidine and thieno-pyridazine compounds and methods of use
11/01/2007CA2649522A1 Medicaments
11/01/2007CA2649512A1 C-fms kinase inhibitors
11/01/2007CA2649509A1 Novel compounds
11/01/2007CA2649458A1 Dicarboxamide derivatives
11/01/2007CA2649272A1 Pharmaceutical composition for conformational disease
11/01/2007CA2649256A1 Therapeutic agent for inflammatory bowel disease
11/01/2007CA2649215A1 2,6,9-trisubstituted purine compounds as adenosine aza receptor modulators
11/01/2007CA2649211A1 Organic compounds
11/01/2007CA2649205A1 Organic compounds
11/01/2007CA2649043A1 Azolecarboxamide derivative
1 ... 3521 3522 3523 3524 3525 3526 3527 3528 3529 3530 3531 3532 3533 3534 3535 3536 3537 3538 3539 3540 3541 ... 7860